bpc-157 human clinical trial evidence safety Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D bpc-157 human clinical trials evidence
Description
More detail on exact manufacturing locations would likely be provided upon request
Generally, a BAC of around 0.40% and higher can be fatal for many individuals
Initial Treatment Dosage: 1000 mcg Daily Protocol Adults with a severe B12 deficiency usually start with 1000 mcg daily for one week
(July 2018)
The observation of reticulocytosis which usually occurs between the third and tenth day of therapy confirms the diagnosis of vitamin B12 deficiency
Example schedule only
